| 胡彦婷,汪瑜,熊德建,等.阿托伐他汀联合葛根素对激素性股骨头缺血性坏死的作用机制研究[J].安徽医药,2020,24(6):1070-1074. |
| 阿托伐他汀联合葛根素对激素性股骨头缺血性坏死的作用机制研究 |
| Mechanism of combined application of atorvastatin and puerarin on SANFH rats |
| |
| DOI：10.3969/j.issn.1009?6469.2020.06.003 |
| 中文关键词: 股骨头坏死 /药物疗法 核因子 κB受体活化因子 RANK配体 骨保护素 碱性磷酸酶 肿瘤坏死因子受体相关因子?6(TRAF?6) 阿托伐他汀 葛根素 |
| 英文关键词: Femur head necrosis/drug therapy Receptor activator of nuclear factor?kappa B RANK ligand Osteoproteger? in Alkaline phosphatase Tumor necrosis factor receptor associated factor 6(TRAF?6) Atorvastatin Puerarin |
| 基金项目: |
|
| 摘要点击次数: 1890 |
| 全文下载次数: 515 |
| 中文摘要: |
| 目的研究阿托伐他汀和葛根素对股骨头缺血性坏死大鼠的治疗作用及作用机制。方法 50只 SD大鼠采用随机数字表法分为空白组、模型组、阿托伐他汀组、葛根素组、联合用药组，每组 10只。除空白组外，其余各组用脂多糖联合甲强龙建立大鼠激素性股骨头缺血性坏死模型。各组大鼠用对应药物灌胃给药，连续 8周。酶联免疫吸附剂测定( ELISA)检测大鼠血清中碱性磷酸酶( ALP)和转化生长因子 β1(TGF?β1)的含量；苏木精 ?伊红( HE)染色观察病理变化及 DNA断裂的原位末端标记法( TUNEL法)观察细胞凋亡；实时荧光定量 PCR(qPCR)检测核因子 ?κB受体活化因子( RANK)和核因子 ?κB受体活化因子配基( RANKL)mRNA，并用蛋白质印迹法( Western Blot)检测骨保护蛋白( OPG)、 RANK、RANKL和肿瘤坏死因子受体相关因子 6(TRAF?6)蛋白表达。结果空白组大鼠血清中 ALP和 TGF?β1含量分别为( 25.23±1.24)IU/L和( 47.12±2.41)ng/mL，而模型组大鼠血清中 ALP含量升高， TGF?β1含量降低，分别为( 31.86±1.23)IU/L和( 37.74±2.68)ng/mL；与模型组相比，联合用药组能够降低 ALP和升高 TGF?β1含量( P＜0.01)，分别为( 26.96±1.54)IU/L和( 44.12±2.42)ng/mL；HE染色结果显示模型组大鼠股骨头组织被破坏，血管减少；联合用药组的软骨细胞排列整齐，骨髓腔内有大量造血细胞，脂肪细胞分布均匀。 RT?PCR和蛋白质印迹法结果显示模型组 OPG、RANK、RANKL和 TRAF?6表达量升高。与模型组相比，联合用药组能提高 OPG、RANK和降低 RANKL、TRAF?6表达量( P＜0.05)。结论阿托伐他汀联合葛根素可有效治疗激素性股骨头缺血性坏死，作用机制可能与 OPG/RANKL/RANK信号通路有关。 |
| 英文摘要: |
| Objective To explore the effects and mechanism of combined application of atorvastatin and puerarin on steroid?in?duced avascular necrosis of femoral head(SANFH)rats.Methods Fifty SD rats were randomly assigned into five groups(n＝10 for each group): blank group，model group，atorvastatin group，puerarin group and combined treatment group.SANFH rat models were established by lipopolysaccharide(LPS)combined with methylprednisolone in all the groups except for the blank group.Allanimals were treated with appropriate drugs for 8 weeks.The alkaline phosphatase(ALP)and transforming growth factorβ1(TGF?β1) contents were measured by enzyme linked immunosorbent assay(ELISA).The changes and apoptosis of femoral head were ob? served through haematoxylin?eosin(HE)staining and TdT?mediated dUTP nick end labeling(TUNEL)of DNA fragmentation，re? spectively. Receptor activator of NF?κB(RANK)and receptor activator of NF?κB ligand(RANKL)mRNA were detected by Real? time fluorescent quantitative polymerase chain reaction(RT?PCR) and expressions of bone protection protein(OPG)， RANK， RANKL and tumor necrosis factor receptor?related factor 6(TRAF?6)protein were measured by Western blotting.Results The se? rum ALP and TGF?β1 contents in the blank group were(25.23±1.24)IU/L and(47.12±2.41)ng/mL，respectively，while the serum ALP content in the model group was increased and TGF?β1 content was decreased，which were(31.86±1.23)IU/L and(37.74± |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
